Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 441 clinical trials
featured
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support (Protocol No. HL-CA-5000)

A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support (Protocol No. HL-CA-5000)  

  • 36 views
  • 11 Jun, 2020
  • 1 location
featured
The AIRWISE Study: Assessment In a Real World setting of the effect of Inhaled Steroid-based triple therapy versus the combination of tiotropium and olodaterol on reducing COPD Exacerbations

Patients diagnosed with COPD will be approached and asked to complete Questionnaires. These questionnaires will help guide the sponsor as to what patients thinks which works better, being on triple therapy or combo therapy when dealing with COPD and exacerbations  

  • 54 views
  • 11 Jun, 2020
  • 1 location
featured
A Washington University research study is currently enrolling participants with COPD.

The study will last approximately 68 weeks. There will be study visits every 2 to 4 weeks (1 to 3 hours each). Participation includes physical exam, blood and urine tests, COPD assessment, spirometry (breathing test), questionnaires, and chest imaging. Compensation is provided for time and effort. Costs for COPD controller …

chronic obstructive pulmonary disease (copd)
pulmonary diseases
COPD
pulmonary disease
chronic obstructive pulmonary disease
  • 0 views
  • 12 Jan, 2021
  • 1 location
featured
A Phase III Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 Weeks in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease.

This study will enroll approximately 800 patients with moderate to severe COPD in 2 subsets. The 24-week subset will enroll approximately 400 patients randomized 1:1 ensifentrine (3 mg): placebo and the 48-week subset will enroll approximately 400 patients randomized 3:1 in order to minimize the number of patients assigned to …

  • 156 views
  • 23 Nov, 2020
  • 1 location
featured
COPD Exacerbation Research Study

Looking for patients at least 40 years of age who have been diagnosed with COPD and recently had several events of worsening of symptoms.  

  • 57 views
  • 23 Nov, 2020
  • 1 location
featured
NO 0050-0637

ICON Early Phase Services is conducting a non-interventional device research study adults age 40+ who are either healthy, or, have chronic obstructive pulmonary disease (COPD). This study is being

  • 105 views
  • 23 Nov, 2020
  • 1 location
featured
COPD (Chronic Obstructive Pulmonary Disease)

COPD (Chronic Obstructive Pulmonary Disease)

  • 104 views
  • 25 Mar, 2021
  • 1 location
featured
COPD (Chronic Obstructive Pulmonary Disease)

COPD (Chronic Obstructive Pulmonary Disease)

  • 442 views
  • 23 Nov, 2020
  • 1 location
featured
Now Enrolling - Chronic Obstructive Pulmonary Disease (COPD) Research Study

Now Enrolling - Chronic Obstructive Pulmonary Disease (COPD) Research Study

  • 342 views
  • 23 Nov, 2020
  • 3 locations
featured
Research Study for Chronic Obstructive Pulmonary Disease (COPD)

Research Study for Chronic Obstructive Pulmonary Disease (COPD)

  • 302 views
  • 08 Nov, 2020
  • 1 location